Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1.
An outbreak of influenza H1N1 in 2009, representing the first influenza pandemic of the 21st century, was transmitted to over a million individuals and claimed 18,449 lives. The current status in many countries is to prepare influenza vaccine using cell-based or egg-based killed vaccine. However, tr...
Main Authors: | Yong-Dae Gwon, Sehyun Kim, Yeondong Cho, Yoonki Heo, Hansam Cho, Kihoon Park, Hee-Jung Lee, Jiwon Choi, Haryoung Poo, Young Bong Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4858234?pdf=render |
Similar Items
-
Immunogenicity of a trivalent human papillomavirus L1 DNA-encapsidated, non-replicable baculovirus nanovaccine.
by: Hansam Cho, et al.
Published: (2014-01-01) -
Development of Zika Virus DNA Vaccine Using Envelope Modified Baculoviral Gene Delivery System
by: Hanul Choi, et al.
Published: (2020-06-01) -
Immunogenicity of bivalent human papillomavirus DNA vaccine using human endogenous retrovirus envelope-coated baculoviral vectors in mice and pigs.
by: Hee-Jung Lee, et al.
Published: (2012-01-01) -
Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
by: Hansam Cho, et al.
Published: (2021-03-01) -
Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009.
by: Jae-Yoo Choi, et al.
Published: (2013-01-01)